An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous viruses

This publication has 25 references indexed in Scilit:

• Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine
  The Lancet, 1993
• Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?
  The Lancet, 1992
• Inactivated Whole SIV Vaccine in Macaques: Evaluation of Protective Efficacy Against Challenge with Cell-Free Virus or Infected Cells
  AIDS Research and Human Retroviruses, 1992
• Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus
  The Lancet, 1992
• Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLH
  International Journal of Immunopharmacology, 1991
• A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1991
• Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine
  The Lancet, 1990
• Vaccine Protection of Rhesus Macaques Against Simian Immunodeficiency Virus Infection
  AIDS Research and Human Retroviruses, 1990
• Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160
  Nature, 1990
• A Formalin-Inactivated Whole SIV Vaccine Confers Protection in Macaques
  Science, 1989